Global Pharmacovigilance (PV) Outsourcing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Pharmacovigilance (PV) Outsourcing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pharmacovigilance (PV) Outsourcing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Premarketing Clinical Trial accounting for % of the Pharmacovigilance (PV) Outsourcing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Contract Research Organizations (CROs) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pharmacovigilance (PV) Outsourcing include Accenture, C3i Solutions, Clintec, Covance, and Deloitte Touche Tohmatsu Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmacovigilance (PV) Outsourcing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
Market segment by Application, can be divided into
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
Market segment by players, this report covers
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pharmacovigilance (PV) Outsourcing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmacovigilance (PV) Outsourcing, with revenue, gross margin and global market share of Pharmacovigilance (PV) Outsourcing from 2019 to 2022.
Chapter 3, the Pharmacovigilance (PV) Outsourcing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmacovigilance (PV) Outsourcing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pharmacovigilance (PV) Outsourcing research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Pharmacovigilance (PV) Outsourcing
1.2 Classification of Pharmacovigilance (PV) Outsourcing by Type
1.2.1 Overview: Global Pharmacovigilance (PV) Outsourcing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type in 2021
1.2.3 Contract Research Organizations (CROs)
1.2.4 Business Process Outsourcing (BPOs)
1.3 Global Pharmacovigilance (PV) Outsourcing Market by Application
1.3.1 Overview: Global Pharmacovigilance (PV) Outsourcing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Premarketing Clinical Trial
1.3.3 Post-marketing Clinical Practice
1.3.4 Other
1.4 Global Pharmacovigilance (PV) Outsourcing Market Size & Forecast
1.5 Global Pharmacovigilance (PV) Outsourcing Market Size and Forecast by Region
1.5.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Region, (2017-2022)
1.5.3 North America Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2017-2028)
1.5.4 Europe Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2017-2028)
1.5.6 South America Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmacovigilance (PV) Outsourcing Market Drivers
1.6.2 Pharmacovigilance (PV) Outsourcing Market Restraints
1.6.3 Pharmacovigilance (PV) Outsourcing Trends Analysis
2 Company Profiles
2.1 Accenture
2.1.1 Accenture Details
2.1.2 Accenture Major Business
2.1.3 Accenture Pharmacovigilance (PV) Outsourcing Product and Solutions
2.1.4 Accenture Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Accenture Recent Developments and Future Plans
2.2 C3i Solutions
2.2.1 C3i Solutions Details
2.2.2 C3i Solutions Major Business
2.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Product and Solutions
2.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 C3i Solutions Recent Developments and Future Plans
2.3 Clintec
2.3.1 Clintec Details
2.3.2 Clintec Major Business
2.3.3 Clintec Pharmacovigilance (PV) Outsourcing Product and Solutions
2.3.4 Clintec Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Clintec Recent Developments and Future Plans
2.4 Covance
2.4.1 Covance Details
2.4.2 Covance Major Business
2.4.3 Covance Pharmacovigilance (PV) Outsourcing Product and Solutions
2.4.4 Covance Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Covance Recent Developments and Future Plans
2.5 Deloitte Touche Tohmatsu Limited
2.5.1 Deloitte Touche Tohmatsu Limited Details
2.5.2 Deloitte Touche Tohmatsu Limited Major Business
2.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product and Solutions
2.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Deloitte Touche Tohmatsu Limited Recent Developments and Future Plans
2.6 ELC Group
2.6.1 ELC Group Details
2.6.2 ELC Group Major Business
2.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Product and Solutions
2.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 ELC Group Recent Developments and Future Plans
2.7 Ergomed
2.7.1 Ergomed Details
2.7.2 Ergomed Major Business
2.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Product and Solutions
2.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Ergomed Recent Developments and Future Plans
2.8 iGATE Corporation
2.8.1 iGATE Corporation Details
2.8.2 iGATE Corporation Major Business
2.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
2.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 iGATE Corporation Recent Developments and Future Plans
2.9 iMED Global Corporation
2.9.1 iMED Global Corporation Details
2.9.2 iMED Global Corporation Major Business
2.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
2.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 iMED Global Corporation Recent Developments and Future Plans
2.10 IQVIA
2.10.1 IQVIA Details
2.10.2 IQVIA Major Business
2.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Product and Solutions
2.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 IQVIA Recent Developments and Future Plans
2.11 MarksMan Healthcare
2.11.1 MarksMan Healthcare Details
2.11.2 MarksMan Healthcare Major Business
2.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product and Solutions
2.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 MarksMan Healthcare Recent Developments and Future Plans
2.12 Medpace Holdings
2.12.1 Medpace Holdings Details
2.12.2 Medpace Holdings Major Business
2.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product and Solutions
2.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Medpace Holdings Recent Developments and Future Plans
2.13 Novartis
2.13.1 Novartis Details
2.13.2 Novartis Major Business
2.13.3 Novartis Pharmacovigilance (PV) Outsourcing Product and Solutions
2.13.4 Novartis Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Novartis Recent Developments and Future Plans
2.14 Oracle Corporation
2.14.1 Oracle Corporation Details
2.14.2 Oracle Corporation Major Business
2.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
2.14.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Oracle Corporation Recent Developments and Future Plans
2.15 Parexel
2.15.1 Parexel Details
2.15.2 Parexel Major Business
2.15.3 Parexel Pharmacovigilance (PV) Outsourcing Product and Solutions
2.15.4 Parexel Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Parexel Recent Developments and Future Plans
2.16 PharmInvent
2.16.1 PharmInvent Details
2.16.2 PharmInvent Major Business
2.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Product and Solutions
2.16.4 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 PharmInvent Recent Developments and Future Plans
2.17 PrimeVigilance
2.17.1 PrimeVigilance Details
2.17.2 PrimeVigilance Major Business
2.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product and Solutions
2.17.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 PrimeVigilance Recent Developments and Future Plans
2.18 Pure Drug Safety
2.18.1 Pure Drug Safety Details
2.18.2 Pure Drug Safety Major Business
2.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product and Solutions
2.18.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Pure Drug Safety Recent Developments and Future Plans
2.19 Sciformix
2.19.1 Sciformix Details
2.19.2 Sciformix Major Business
2.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Product and Solutions
2.19.4 Sciformix Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Sciformix Recent Developments and Future Plans
2.20 SIRO Clinpharm
2.20.1 SIRO Clinpharm Details
2.20.2 SIRO Clinpharm Major Business
2.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product and Solutions
2.20.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 SIRO Clinpharm Recent Developments and Future Plans
2.21 Symogen
2.21.1 Symogen Details
2.21.2 Symogen Major Business
2.21.3 Symogen Pharmacovigilance (PV) Outsourcing Product and Solutions
2.21.4 Symogen Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Symogen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmacovigilance (PV) Outsourcing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharmacovigilance (PV) Outsourcing Players Market Share in 2021
3.2.2 Top 10 Pharmacovigilance (PV) Outsourcing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pharmacovigilance (PV) Outsourcing Players Head Office, Products and Services Provided
3.4 Pharmacovigilance (PV) Outsourcing Mergers & Acquisitions
3.5 Pharmacovigilance (PV) Outsourcing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pharmacovigilance (PV) Outsourcing Revenue and Market Share by Type (2017-2022)
4.2 Global Pharmacovigilance (PV) Outsourcing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2017-2022)
5.2 Global Pharmacovigilance (PV) Outsourcing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2028)
6.2 North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2028)
6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Country
6.3.1 North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2017-2028)
6.3.2 United States Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
6.3.3 Canada Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
6.3.4 Mexico Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2028)
7.2 Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2028)
7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country
7.3.1 Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2017-2028)
7.3.2 Germany Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
7.3.3 France Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
7.3.5 Russia Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
7.3.6 Italy Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2028)
8.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2028)
8.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region
8.3.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Region (2017-2028)
8.3.2 China Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
8.3.3 Japan Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
8.3.4 South Korea Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
8.3.5 India Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
8.3.7 Australia Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2028)
9.2 South America Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2028)
9.3 South America Pharmacovigilance (PV) Outsourcing Market Size by Country
9.3.1 South America Pharmacovigilance (PV) Outsourcing Revenue by Country (2017-2028)
9.3.2 Brazil Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
9.3.3 Argentina Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2028)
10.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2028)
10.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country
10.3.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Country (2017-2028)
10.3.2 Turkey Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
10.3.4 UAE Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Pharmacovigilance (PV) Outsourcing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pharmacovigilance (PV) Outsourcing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pharmacovigilance (PV) Outsourcing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pharmacovigilance (PV) Outsourcing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Region (2023-2028)
Table 6. Accenture Corporate Information, Head Office, and Major Competitors
Table 7. Accenture Major Business
Table 8. Accenture Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 9. Accenture Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. C3i Solutions Corporate Information, Head Office, and Major Competitors
Table 11. C3i Solutions Major Business
Table 12. C3i Solutions Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 13. C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Clintec Corporate Information, Head Office, and Major Competitors
Table 15. Clintec Major Business
Table 16. Clintec Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 17. Clintec Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Covance Corporate Information, Head Office, and Major Competitors
Table 19. Covance Major Business
Table 20. Covance Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 21. Covance Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Deloitte Touche Tohmatsu Limited Corporate Information, Head Office, and Major Competitors
Table 23. Deloitte Touche Tohmatsu Limited Major Business
Table 24. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 25. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. ELC Group Corporate Information, Head Office, and Major Competitors
Table 27. ELC Group Major Business
Table 28. ELC Group Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 29. ELC Group Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Ergomed Corporate Information, Head Office, and Major Competitors
Table 31. Ergomed Major Business
Table 32. Ergomed Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 33. Ergomed Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. iGATE Corporation Corporate Information, Head Office, and Major Competitors
Table 35. iGATE Corporation Major Business
Table 36. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 37. iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. iMED Global Corporation Corporate Information, Head Office, and Major Competitors
Table 39. iMED Global Corporation Major Business
Table 40. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 41. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. IQVIA Corporate Information, Head Office, and Major Competitors
Table 43. IQVIA Major Business
Table 44. IQVIA Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 45. IQVIA Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. MarksMan Healthcare Corporate Information, Head Office, and Major Competitors
Table 47. MarksMan Healthcare Major Business
Table 48. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 49. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Medpace Holdings Corporate Information, Head Office, and Major Competitors
Table 51. Medpace Holdings Major Business
Table 52. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 53. Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Novartis Corporate Information, Head Office, and Major Competitors
Table 55. Novartis Major Business
Table 56. Novartis Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 57. Novartis Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Oracle Corporation Corporate Information, Head Office, and Major Competitors
Table 59. Oracle Corporation Major Business
Table 60. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 61. Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Parexel Corporate Information, Head Office, and Major Competitors
Table 63. Parexel Major Business
Table 64. Parexel Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 65. Parexel Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. PharmInvent Corporate Information, Head Office, and Major Competitors
Table 67. PharmInvent Major Business
Table 68. PharmInvent Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 69. PharmInvent Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. PrimeVigilance Corporate Information, Head Office, and Major Competitors
Table 71. PrimeVigilance Major Business
Table 72. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 73. PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Pure Drug Safety Corporate Information, Head Office, and Major Competitors
Table 75. Pure Drug Safety Major Business
Table 76. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 77. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Sciformix Corporate Information, Head Office, and Major Competitors
Table 79. Sciformix Major Business
Table 80. Sciformix Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 81. Sciformix Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. SIRO Clinpharm Corporate Information, Head Office, and Major Competitors
Table 83. SIRO Clinpharm Major Business
Table 84. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 85. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Symogen Corporate Information, Head Office, and Major Competitors
Table 87. Symogen Major Business
Table 88. Symogen Pharmacovigilance (PV) Outsourcing Product and Solutions
Table 89. Symogen Pharmacovigilance (PV) Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Global Pharmacovigilance (PV) Outsourcing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 91. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 92. Breakdown of Pharmacovigilance (PV) Outsourcing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Pharmacovigilance (PV) Outsourcing Players Head Office, Products and Services Provided
Table 94. Pharmacovigilance (PV) Outsourcing Mergers & Acquisitions in the Past Five Years
Table 95. Pharmacovigilance (PV) Outsourcing New Entrants and Expansion Plans
Table 96. Global Pharmacovigilance (PV) Outsourcing Revenue (USD Million) by Type (2017-2022)
Table 97. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Type (2017-2022)
Table 98. Global Pharmacovigilance (PV) Outsourcing Revenue Forecast by Type (2023-2028)
Table 99. Global Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2022)
Table 100. Global Pharmacovigilance (PV) Outsourcing Revenue Forecast by Application (2023-2028)
Table 101. North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 102. North America Pharmacovigilance (PV) Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 103. North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 104. North America Pharmacovigilance (PV) Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 105. North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2017-2022) & (USD Million)
Table 106. North America Pharmacovigilance (PV) Outsourcing Revenue by Country (2023-2028) & (USD Million)
Table 107. Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 108. Europe Pharmacovigilance (PV) Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 109. Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 110. Europe Pharmacovigilance (PV) Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 111. Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2017-2022) & (USD Million)
Table 112. Europe Pharmacovigilance (PV) Outsourcing Revenue by Country (2023-2028) & (USD Million)
Table 113. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 114. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 115. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 116. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 117. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Region (2017-2022) & (USD Million)
Table 118. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue by Region (2023-2028) & (USD Million)
Table 119. South America Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 120. South America Pharmacovigilance (PV) Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 121. South America Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 122. South America Pharmacovigilance (PV) Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 123. South America Pharmacovigilance (PV) Outsourcing Revenue by Country (2017-2022) & (USD Million)
Table 124. South America Pharmacovigilance (PV) Outsourcing Revenue by Country (2023-2028) & (USD Million)
Table 125. Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 126. Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 127. Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 128. Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 129. Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Country (2017-2022) & (USD Million)
Table 130. Middle East & Africa Pharmacovigilance (PV) Outsourcing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pharmacovigilance (PV) Outsourcing Picture
Figure 2. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type in 2021
Figure 3. Contract Research Organizations (CROs)
Figure 4. Business Process Outsourcing (BPOs)
Figure 5. Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application in 2021
Figure 6. Premarketing Clinical Trial Picture
Figure 7. Post-marketing Clinical Practice Picture
Figure 8. Other Picture
Figure 9. Global Pharmacovigilance (PV) Outsourcing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Pharmacovigilance (PV) Outsourcing Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Region (2017-2028)
Figure 12. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Region in 2021
Figure 13. North America Pharmacovigilance (PV) Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Pharmacovigilance (PV) Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Pharmacovigilance (PV) Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Pharmacovigilance (PV) Outsourcing Market Drivers
Figure 19. Pharmacovigilance (PV) Outsourcing Market Restraints
Figure 20. Pharmacovigilance (PV) Outsourcing Market Trends
Figure 21. Accenture Recent Developments and Future Plans
Figure 22. C3i Solutions Recent Developments and Future Plans
Figure 23. Clintec Recent Developments and Future Plans
Figure 24. Covance Recent Developments and Future Plans
Figure 25. Deloitte Touche Tohmatsu Limited Recent Developments and Future Plans
Figure 26. ELC Group Recent Developments and Future Plans
Figure 27. Ergomed Recent Developments and Future Plans
Figure 28. iGATE Corporation Recent Developments and Future Plans
Figure 29. iMED Global Corporation Recent Developments and Future Plans
Figure 30. IQVIA Recent Developments and Future Plans
Figure 31. MarksMan Healthcare Recent Developments and Future Plans
Figure 32. Medpace Holdings Recent Developments and Future Plans
Figure 33. Novartis Recent Developments and Future Plans
Figure 34. Oracle Corporation Recent Developments and Future Plans
Figure 35. Parexel Recent Developments and Future Plans
Figure 36. PharmInvent Recent Developments and Future Plans
Figure 37. PrimeVigilance Recent Developments and Future Plans
Figure 38. Pure Drug Safety Recent Developments and Future Plans
Figure 39. Sciformix Recent Developments and Future Plans
Figure 40. SIRO Clinpharm Recent Developments and Future Plans
Figure 41. Symogen Recent Developments and Future Plans
Figure 42. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Players in 2021
Figure 43. Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Pharmacovigilance (PV) Outsourcing Revenue Market Share in 2021
Figure 45. Global Top 10 Players Pharmacovigilance (PV) Outsourcing Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Type in 2021
Figure 48. Global Pharmacovigilance (PV) Outsourcing Market Share Forecast by Type (2023-2028)
Figure 49. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Application in 2021
Figure 50. Global Pharmacovigilance (PV) Outsourcing Market Share Forecast by Application (2023-2028)
Figure 51. North America Pharmacovigilance (PV) Outsourcing Sales Market Share by Type (2017-2028)
Figure 52. North America Pharmacovigilance (PV) Outsourcing Sales Market Share by Application (2017-2028)
Figure 53. North America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Country (2017-2028)
Figure 54. United States Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Pharmacovigilance (PV) Outsourcing Sales Market Share by Type (2017-2028)
Figure 58. Europe Pharmacovigilance (PV) Outsourcing Sales Market Share by Application (2017-2028)
Figure 59. Europe Pharmacovigilance (PV) Outsourcing Revenue Market Share by Country (2017-2028)
Figure 60. Germany Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Pharmacovigilance (PV) Outsourcing Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Pharmacovigilance (PV) Outsourcing Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Pharmacovigilance (PV) Outsourcing Revenue Market Share by Region (2017-2028)
Figure 68. China Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Pharmacovigilance (PV) Outsourcing Sales Market Share by Type (2017-2028)
Figure 75. South America Pharmacovigilance (PV) Outsourcing Sales Market Share by Application (2017-2028)
Figure 76. South America Pharmacovigilance (PV) Outsourcing Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Pharmacovigilance (PV) Outsourcing Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Pharmacovigilance (PV) Outsourcing Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Pharmacovigilance (PV) Outsourcing Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Pharmacovigilance (PV) Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
